Bayer said it will pay $1.6 billion to settle claims that its birth-control device Essure causes serious health complications, the latest in a string of settlements by the German company.

“The Essure 522 study is a five-year observational study that will not be completed for more than four years, and, as a result, the interim findings are incomplete and are subject to change ...

After acquiring original Essure maker Conceptus in 2013, the German conglomerate continued the California-based company’s practice of not reporting complaints to the U.S. Food and Drug ...

Bayer announced Friday it would discontinue sales of its Essure birth control implant by the end of the year, bowing to a lengthy campaign by health advocates and thousands of women to get the ...

Essure is now owned by Bayer Healthcare, which purchased the product from Conceptus, Inc. The Facebook group has now gained a strong ally from environmental activist, ...

A “patient checklist” will also be provided for doctors to discuss with patients and better communicate the potential health risks associated with the contraceptive. The FDA is also ordering a new ...

A US Congressman says the FDA underestimated how many fetal deaths have been related to Essure birth control. 1 weather alerts 1 closings/delays. Watch Now. 1 weather alerts 1 closings/delays.

When Alyson Hannan, 44, decided she was done having children, she chose Essure, a nonsurgical permanent birth control option approved by the Food and Drug Administration. The day the tiny metal ...

WASHINGTON (MEDIA GENERAL) – After suffering symptoms of extreme pelvic pain, bleeding and migraines, former users of a birth control device known as Essure are pushing for Congress to ...

JACKSONVILLE, Fla. -- Cassandra Hardy says she had an Essure device implanted in her fallopian tubes in 2011 so she wouldn't get pregnant again. Two years later, the 29-year-old says, she was ...

Since it was approved to go on the market in 2002, Essure, an implantable permanent contraceptive device, has been plagued by controversy. Thousands of women have filed grievances with the US Food ...

Conceptus is bouncing 18 cents, or 2 percent, to $9.18, in midday trades. The stock lost more than 10 percent in Tuesday's session. After the closing bell, the San Carlos, Calif., medical device ...